相关实验视频

Updated: Mar 13, 2026

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies

Published on: February 23, 2018

对天花病毒感染的交叉中和保护性人类抗体特异性

Iuliia Gilchuk¹, Pavlo Gilchuk², Gopal Sapparapu³

¹The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

|October 22, 2016

概括

研究人员鉴定出人类单克隆抗体 (Abs),可以中和病毒 (MPXV) 和其他骨病毒. 这些Abs提供广泛的保护,可以替代有限的疫苗免疫球蛋白 (VIG) 用于治疗严重的感染.

科学领域:

病毒学
免疫学
传染性疾病

背景情况:

麻疹 (MPXV),牛麻疹 (CPXV) 和麻疹病毒 (VARV) 是严重的骨质麻疹病毒威胁,导致严重的人类感染并构成生物恐怖主义风险.
疫苗免疫球蛋白 (VIG) 是严重的脊髓炎病毒感染的有限治疗选择.

研究的目的:

鉴定针对多种类型的脊髓炎病毒的广泛中和的人类单克隆抗体 (Abs).
为了阐明保护性抗体反应的分子点,以开发潜在的治疗方法.

主要方法:

来自对脊髓炎病毒免疫个体的大量人类单克隆抗体的生成.
对VACV,CPXV,MPXV和VARV的抗体特异性和交叉反应性的详细分析.
在呼吸道和全身感染的小鼠挑战模型中评估抗体疗效.

主要成果:

确定了关键的中和抗体特异性,这些特异性可以在多种骨髓炎病毒中进行交叉反应.
证明了针对各种病毒膜蛋白的Abs组合 (包裹和成熟形式) 对最佳保护至关重要.
在临床前模型中证实了这些Abs的保护作用.

结论:

人类单克隆抗体可以介导广泛的交叉保护性免疫.
特定的病毒膜蛋白是广泛中和抗体的关键目标.
这些发现为开发基于抗体的新疗法铺平了道路,以替代VIG治疗严重的脊髓炎病毒感染.

关键词:

抗原特异性交叉中和人类单克隆抗体感染天花病毒保护性免疫力小天花疫苗

更多相关视频

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies

Published on: August 29, 2017

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Published on: November 21, 2023

相关概念视频

Cross-reactivity

Cross-reactivity

Antigens Involved in Adaptive Immunity

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...